Innovation
FDA Releases Final Classification for Natural Cycles, the First and Only Birth Control App in the U.S.
Natural Cycles
PR-M03-19-NI-031Mar 12, 2019
FDA Acceptance
FDA Accepts Filing of New Estrogen-free Oral Contraceptive Developed by Exeltis
Exeltis
PR-M12-18-NI-030Dec 10, 2018
FDA Approval
TherapeuticsMD Announces FDA Approval of ANNOVERA™ (Segesterone Acetate/Ethinyl Estradiol Vaginal System) for Birth Control
TherapeuticsMD, Inc.
PR-M09-18-NI-002Sep 04, 2018